Normalization of blood pressure-and use of an ACE inhibitor or AT 1- receptor blocker for patients with abnormal albumin or creatinine levels-can prevent or significantly slow the rate of progression toward end-stage renal disease.
|Original language||English (US)|
|Number of pages||12|
|State||Published - Feb 15 1997|
ASJC Scopus subject areas